What is Bio-Rad Laboratories, Inc.Class A's Market Cap?

Bio-Rad Laboratories, Inc.Class A's Market Cap is $10.2B, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's Enterprise Value?

Bio-Rad Laboratories, Inc.Class A's Enterprise Value is $9.4B, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's Trailing P/E?

Bio-Rad Laboratories, Inc.Class A's Trailing P/E is 45.7×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's Price / Sales?

Bio-Rad Laboratories, Inc.Class A's Price / Sales is 3.9×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's EV / Revenue?

Bio-Rad Laboratories, Inc.Class A's EV / Revenue is 3.6×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's EV / EBITDA?

Bio-Rad Laboratories, Inc.Class A's EV / EBITDA is 42.8×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's Revenue (TTM)?

Bio-Rad Laboratories, Inc.Class A's Revenue (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's Net Income (TTM)?

Bio-Rad Laboratories, Inc.Class A's Net Income (TTM) is $222.4M, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's EBITDA?

Bio-Rad Laboratories, Inc.Class A's EBITDA is $218.5M, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc.Class A's Diluted EPS (TTM)?

Bio-Rad Laboratories, Inc.Class A's Diluted EPS (TTM) is 8.32, based on as-reported figures from SEC (XBRL) filings.

Bio-Rad Laboratories, Inc.Class A (BIO) Financial Statements

Bio-Rad Laboratories, Inc.Class A

SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS

FIGI BBG001S625W4

XNYS · usd

380.12▼ 5.99 (-1.55%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close386.11

Day's Range379.49 – 390.73

52-Week Range236.73 – 396.23

Volume138.8K

Avg Volume261.9K

Share Statistics

Shares Outstanding

Employees7,450

ExchangeXNYS

Listed1980-02-29

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Bio-Rad Laboratories, Inc.Class A (BIO)

What is Bio-Rad Laboratories, Inc.Class A's Market Cap?: Bio-Rad Laboratories, Inc.Class A's Market Cap is $10.2B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Enterprise Value?: Bio-Rad Laboratories, Inc.Class A's Enterprise Value is $9.4B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Trailing P/E?: Bio-Rad Laboratories, Inc.Class A's Trailing P/E is 45.7×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Price / Sales?: Bio-Rad Laboratories, Inc.Class A's Price / Sales is 3.9×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's EV / Revenue?: Bio-Rad Laboratories, Inc.Class A's EV / Revenue is 3.6×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's EV / EBITDA?: Bio-Rad Laboratories, Inc.Class A's EV / EBITDA is 42.8×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Revenue (TTM)?: Bio-Rad Laboratories, Inc.Class A's Revenue (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Net Income (TTM)?: Bio-Rad Laboratories, Inc.Class A's Net Income (TTM) is $222.4M, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's EBITDA?: Bio-Rad Laboratories, Inc.Class A's EBITDA is $218.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Diluted EPS (TTM)?: Bio-Rad Laboratories, Inc.Class A's Diluted EPS (TTM) is 8.32, based on as-reported figures from SEC (XBRL) filings.